F. Yurt Onaran Et Al. , "Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells," ACS OMEGA , vol.3, no.2682, pp.1-14, 2023
Yurt Onaran, F. Et Al. 2023. Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells. ACS OMEGA , vol.3, no.2682 , 1-14.
Yurt Onaran, F., Özel, D., Tunçel, A., Gökbayrak, Ö., & Aktaş, S., (2023). Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells. ACS OMEGA , vol.3, no.2682, 1-14.
Yurt Onaran, Fatma Et Al. "Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells," ACS OMEGA , vol.3, no.2682, 1-14, 2023
Yurt Onaran, Fatma Y. Et Al. "Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells." ACS OMEGA , vol.3, no.2682, pp.1-14, 2023
Yurt Onaran, F. Et Al. (2023) . "Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells." ACS OMEGA , vol.3, no.2682, pp.1-14.
@article{article, author={Fatma Yurt Onaran Et Al. }, title={Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells}, journal={ACS OMEGA}, year=2023, pages={1-14} }